CLINICAL_TRIALS
trial_result
· 2016-09-20
Clinical Trial Update: Long-term Efficacy and Safety Study of TAK-085 in Participants With Hypertriglyceridemia [Phase 3]
Summary
Phase 3 long-term efficacy and safety results for TAK-085 in participants with hypertriglyceridemia have been reported.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Takeda | Conditions: Hypertriglyceridemia | Phase 3 | Status: COMPLETED | Results posted: 2016-09-20